Predictive validity of genome-wide polygenic scores for alcohol use from adolescence to young adulthood.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33388637.
- Also identified by DOI 10.1016/j.drugalcdep.2020.108480.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adolescence is a critical period for experimenting with alcohol, and these early experiences have long-term influences on alcohol-related behaviours throughout adulthood. This study examined the utility of genome-wide polygenic scores (GPS) for predicting alcohol use during adolescence and young adulthood. We used GPS based on the Genome-wide association study and Sequencing Consortium of Alcohol and Nicotine use (GSCAN) study on drinks per week to predict alcohol use in a longitudinal, UK-representative sample of unrelated adolescents aged 16 through to 22 years (N<sub>max</sub> = 3390). At age 16, the GSCAN GPS predicted variance in alcohol consumption on a typical day (0.58 %), intake frequency (0.89 %), and hazardous drinking (i.e. ≥6 units at one occasion) (1.07 %). At age 22, the predictive power of the GPS had increased, explaining variance in alcohol consumption (0.61 %), intake frequency (1.69 %), and hazardous drinking (1.19 %). The predictive validity of GPS for phenotypic alcohol use was evident in adolescence and increased in young adulthood. The findings suggest that GPS, which are available from birth, may be potentially useful for identifying individuals at risk for harmful and hazardous alcohol use. However, because the overall effect sizes were small, the utility of the GPS that are currently available is limited for the prediction of individual-level alcohol use.
Medical subject headings
- Alcohol Drinking